JOSE SAUCEDO: Open Payments
NPI 1184265050 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 15 payments from 9 companies in 2025. Trend: 2023 $174 · 2024 $270 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $135 |
| Novo Nordisk Inc | 1 | $124 |
| Insulet Corporation | 4 | $99 |
| Biogen, Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Organon LLC | 1 | $4 |
Products named: Ozempic, Omnipod, FARXIGA, ZURZUVAE, AIRSUPRA, FREESTYLE LIBRE, APTIMA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
